Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.8320
+0.0219 (2.70%)
At close: Feb 13, 2026, 4:00 PM EST
0.8292
-0.0028 (-0.34%)
After-hours: Feb 13, 2026, 7:48 PM EST
Senti Biosciences Market Cap
Senti Biosciences has a market cap or net worth of $21.87 million as of February 13, 2026. Its market cap has increased by 2.47% in one year.
Market Cap
21.87M
Enterprise Value
39.22M
1-Year Change
2.47%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since May 26, 2021, Senti Biosciences's market cap has decreased from $256.04M to $21.87M, a decrease of -91.46%. That is a compound annual growth rate of -40.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 21.87M | -20.00% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | 256.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 24.53M |
| Daré Bioscience | 24.29M |
| Marker Therapeutics | 23.84M |
| Skye Bioscience | 23.20M |
| Polyrizon | 22.08M |
| Neuphoria Therapeutics | 21.78M |
| NanoViricides | 21.57M |
| Genenta Science | 20.62M |